Your browser doesn't support javascript.
loading
miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
Hu, Jing-Ye; Yi, Wei; Wei, Xuan; Zhang, Mei-Yin; Xu, Rui; Zeng, Li-Si; Huang, Zhi-Jie; Chen, Jing-Song.
Affiliation
  • Hu JY; Department of Basic Medicine, Guiyang College of Traditional Chinese Medicine, Guiyang 550002, People's Republic of China.
  • Yi W; Department of Radiation Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People's Republic of China.
  • Wei X; Department of Radiation Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People's Republic of China.
  • Zhang MY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Xu R; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Zeng LS; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Huang ZJ; Department of General Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People's Republic of China.
  • Chen JS; Department of General Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People's Republic of China. Electronic address: hychenjs@126.com.
Biomed Pharmacother ; 79: 247-53, 2016 Apr.
Article in En | MEDLINE | ID: mdl-27044835
ABSTRACT
MicroRNAs (miRNA) play important roles in the initiation and progression of breast cancer. Here, we investigated the role of miR-601 in breast cancer and found that its expression was significantly down-regulated in breast cancer tissues compared with matched adjacent non-cancerous breast tissues. Moreover, we found that down-regulation of miR-601 was closely associated with distant metastasis and poor distant metastasis-free survival in breast cancer. In addition, miR-601 levels were inversely correlated with metastatic potential of human breast cancer cell lines. Further experiments showed that ectopic overexpression of miR-601 suppressed breast cancer cell proliferation, migration and invasion, whereas miR-601 knockdown promoted breast cancer cell proliferation, migration and invasion. Furthermore, protein tyrosine phosphatase type IVA 1 (PTP4A1) was identified as a direct target of miR-601. Overexpression of miR-601 repressed PTP4A1 mRNA and protein expression. Conversely, inhibition of miR-601 increased PTP4A1 mRNA and protein expression. Taken together, our data suggest that miR-601 inhibits growth and invasion of breast cancer cells by targeting PTP4A1 and that miR-601 is a potential biomarker for prognosis and therapeutic target in breast cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Protein Tyrosine Phosphatases / Cell Cycle Proteins / MicroRNAs / Membrane Proteins Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Biomed Pharmacother Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Protein Tyrosine Phosphatases / Cell Cycle Proteins / MicroRNAs / Membrane Proteins Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Biomed Pharmacother Year: 2016 Document type: Article